Expression Table for this CRE
| CNhs14375 | hematopoietic stem cell, bone marrow derived, embryo E19.5 | 15.5 |
| CNhs13697 | Tracheal epithelial cells, differentiation to ciliated epithelial cells, 020hr, biol_rep1 | 8.7 |
| CNhs10582 | intestine, embryo E17 | 8.6 |
| CNhs10583 | lung, embryo E18 | 8.5 |
| CNhs10520 | liver, embryo E15 | 7.9 |
| CNhs11193 | stomach, neonate N03 | 7.1 |
| CNhs10577 | forelimb, embryo E14 | 6.7 |
| CNhs10595 | thymus, embryo E18 | 6.6 |
| CNhs10514 | whole body, embryo E16 | 6.2 |
| CNhs11209 | heart, neonate N16 | 6.1 |
| CNhs14548 | J2E erythroblastic leukemia response to erythropoietin, 02hr00min, biol_rep3 | 6.1 |
| SRX690780 | Mdr2-KO liver male etiology/histology:10% AD, 70% HCC | 6.0 |
| CNhs11483 | macrophage, TB infection, stimulated BMDM+IL-13(aaMph), without Mtb, 120hr, biol_rep1 | 5.7 |
| CNhs11140 | eyeball, neonate N01 | 5.6 |
| SRX690778 | Mdr2-KO liver male etiology/histology:20% AD, 70% HCC | 5.4 |
| CNhs14553 | Mouse hepatocyte, donor5 | 5.4 |
| CNhs10513 | whole body, embryo E17.5 | 5.2 |
| SRX690776 | Mdr2-KO liver male etiology/histology:20% AD, 50% HCC | 4.8 |
| CNhs10594 | liver, embryo E14 | 4.6 |
| CNhs10523 | liver, embryo E16 | 4.6 |
| SRX690781 | Mdr2-KO liver male etiology/histology:20% AD, 80% HCC | 4.6 |
| CNhs11588 | macrophage, TB infection, stimulated BMDM+IFNg(caMph), with Mtb, 036hr(012h after stimulation), biol_rep2 | 4.5 |
| CNhs10589 | forelimb, embryo E13 | 4.4 |
| SRX690777 | Mdr2-KO liver male etiology/histology:0% AD, 90% HCC | 4.4 |
| CNhs14123 | ES-46C derived epistem cells, biol_rep1 | 4.4 |
| CNhs14099 | ES-Ert2 embryonic stem cells, untreated control, 48hr, biol_rep2 | 4.4 |
| CNhs11027 | testis, embryo E18 | 4.3 |
| CNhs12988 | EBF KO HPCs induced to T cell, 10hr, biol_rep2 | 4.1 |
| SRX690779 | Mdr2-KO liver male etiology/histology:20% AD, 70% HCC | 4.1 |
| SRX690775 | Mdr2-KO liver female etiology/histology:0% AD, 50% HCC | 3.9 |
| CNhs14110 | ES-46C embryonic stem cells, neuronal differentiation, day01, biol_rep2 | 3.9 |
| CNhs11004 | adrenal gland, embryo E16 | 3.8 |
| CNhs13006 | cerebellum, embryo E15, biol_rep2 (E15R2) | 3.7 |
| SRX690774 | Mdr2-KO liver male etiology/histology:70% AD, 20% HCC | 3.7 |
| CNhs13263 | ST2 (Mesenchymal stem cells) cells, differentiation to osteocytes, 03hr, biol_rep2 (003hB2) | 3.7 |
| CNhs11622 | macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), with Mtb, 028hr(004h after stimulation), biol_rep2 | 3.6 |
| CNhs10581 | thymus, embryo E17 | 3.6 |
| CNhs14119 | ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep2 | 3.5 |
| CNhs11221 | heart, neonate N03 | 3.5 |
| CNhs10524 | liver, embryo E13 | 3.5 |
| CNhs14547 | J2E erythroblastic leukemia response to erythropoietin, 00hr00min, biol_rep3 | 3.5 |
| CNhs11462 | macrophage, TB infection, non-stimulated BMDM, without Mtb, 072hr, biol_rep1 | 3.5 |
| CNhs14088 | ES-OS25 embryonic stem cells, flavopiridol treatment, 01hr, biol_rep1 | 3.4 |
| CNhs11478 | macrophage, TB infection, stimulated BMDM+IL-13(aaMph), without Mtb, 024hr, biol_rep1 | 3.3 |
| CNhs11060 | EBF KO HPCs induced to T cell, day06, biol_rep1 | 3.1 |
| CNhs11041 | thymus, embryo E14 | 3.1 |
| CNhs11093 | mouse fibroblast cell line: CRL-1658 NIH/3T3 | 3.0 |
| CNhs12819 | cerebellum, neonate N06, biol_rep1 (P6R1) | 3.0 |
| CNhs12957 | cerebellum, embryo E12, biol_rep1 (E12R1) | 3.0 |
| CNhs11059 | EBF KO HPCs induced to T cell, day03, biol_rep1 | 3.0 |